Dr. Nahid Bhadelia, MD, MA is an infectious diseases physician, Associate Professor at the Boston University School of Medicine and the Medical Director of Special Pathogens Unit (SPU) at Boston Medical Center. The SPU provides medical backup to the maximum containment research (BSL4) conducted at the National Emerging Infectious Diseases Laboratory (NEIDL) at Boston University (BU). Her specialization is in infection control issues related to emerging pathogens and highly communicable infectious diseases. She serves on national and interagency groups focused on medical countermeasures, the intersection between public health preparedness, research and clinical care for emerging pathogens. She currently serves as the clinical lead for the Joint Mobile Emerging Disease Intervention Clinical Capability (JMEDICC) program which a joint US-Ugandan effort to create clinical research capacity to combat viral hemorrhagic fevers in Uganda at the border of Democratic Republic of Congo.
Aside from her clinical training in infectious diseases, she has a master’s degree in international affairs from the Fletcher School of Law and Diplomacy and a background in health and human security with a focus on the impact of pandemics on macro level health indicators and community security. During the West African Ebola epidemic, she served as a clinician in several Ebola treatment units, working with World Health Organization and Partners in Health. She has served as a subject matter expert to US Centers for Disease Control and Prevention, Department of Defense, Global Fund to Fight AIDS, Tuberculosis and Malaria, and World Bank. Dr. Bhadelia is also an Adjunct Associate Professor at the Institute of Human Security at the Tufts Fletcher School of Law and Diplomacy, where she teaches a course on human security and emerging infectious diseases.
- Faculty, National Emerging Infectious Disease Lab, Boston University
- Member, Evans Center for Interdisciplinary Biomedical Research, Boston University
- Tufts University School of Medicine, MD
- Tufts University, BS
- Published on 10/15/2020
Alwan NA, Burgess RA, Ashworth S, Beale R, Bhadelia N, Bogaert D, Dowd J, Eckerle I, Goldman LR, Greenhalgh T, Gurdasani D, Hamdy A, Hanage WP, Hodcroft EB, Hyde Z, Kellam P, Kelly-Irving M, Krammer F, Lipsitch M, McNally A, McKee M, Nouri A, Pimenta D, Priesemann V, Rutter H, Silver J, Sridhar D, Swanton C, Walensky RP, Yamey G, Ziauddeen H. Scientific consensus on the COVID-19 pandemic: we need to act now. Lancet. 2020 Oct 31; 396(10260):e71-e72. PMID: 33069277.
- Published on 7/25/2020
Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler LM, Bhadelia N, Fagan MA, Linas BP, Assoumou SA, Ieong MH, Lin NH, Cooper ER, Brade KD, White LF, Barlam TF, Sagar M. Early administration of interleukin-6 inhibitors for patients with severe COVID-19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int J Infect Dis. 2020 Oct; 99:28-33. PMID: 32721528.
- Published on 3/18/2020
Ayebare R, Waitt P, Okello S, Kayiira M, Atim Ajok M, Nakatudde I, Bhadelia N, Lamorde M. Leveraging investments in Ebola preparedness for COVID-19 in Sub-Saharan Africa. AAS Open Res. 2020; 3:3. PMID: 32500116.
- Published on 3/1/2020
Martins KA, Ayebare RR, Bhadelia N, Kiweewa F, Waitt P, Mimbe D, Okello S, Naluyima P, Brett-Major DM, Lawler JV, Millard M, Walwema R, Cardile AP, Ritchie C, Kwiecien A, Badu H, Espinosa BJ, Beckett C, Bavari S, Zaman S, Christopher G, Clark DV, Lamorde M, Kibuuka H. Pre-positioned Outbreak Research: The Joint Medical Emerging Diseases Intervention Clinical Capability Experience in Uganda. Health Secur. 2020 Mar/Apr; 18(2):114-124. PMID: 32324070.
- Published on 2/1/2020
Bhadelia N. Coronavirus: hospitals must learn from past pandemics. Nature. 2020 02; 578(7794):193. PMID: 32047315.
- Published on 1/1/2020
Asundi A, Bhadelia N. Making Emergency Use of Experimental Vaccines Safer. AMA J Ethics. 2020 01 01; 22(1):E43-49. PMID: 31958390.
- Published on 7/19/2019
McLellan S, Kortepeter MG, Bhadelia N, Shenoy ES, Sauer LM, Frank MG, Cieslak TJ. Ebola in the DRC one year later - Boiling the frog? Int J Infect Dis. 2019 08; 85:212-213. PMID: 31330320.
- Published on 5/1/2019
Kuhn JH, Adachi T, Adhikari NKJ, Arribas JR, Bah IE, Bausch DG, Bhadelia N, Borchert M, Brantsæter AB, Brett-Major DM, Burgess TH, Chertow DS, Chute CG, Cieslak TJ, Colebunders R, Crozier I, Davey RT, de Clerck H, Delgado R, Evans L, Fallah M, Fischer WA, Fletcher TE, Fowler RA, Grünewald T, Hall A, Hewlett A, Hoepelman AIM, Houlihan CF, Ippolito G, Jacob ST, Jacobs M, Jakob R, Jacquerioz FA, Kaiser L, Kalil AC, Kamara RF, Kapetshi J, Klenk HD, Kobinger G, Kortepeter MG, Kraft CS, Kratz T, Bosa HSK, Lado M, Lamontagne F, Lane HC, Lobel L, Lutwama J, Lyon GM, Massaquoi MBF, Massaquoi TA, Mehta AK, Makuma VM, Murthy S, Musoke TS, Muyembe-Tamfum JJ, Nakyeyune P, Nanclares C, Nanyunja M, Nsio-Mbeta J, O'Dempsey T, Paweska JT, Peters CJ, Piot P, Rapp C, Renaud B, Ribner B, Sabeti PC, Schieffelin JS, Slenczka W, Soka MJ, Sprecher A, Strong J, Swanepoel R, Uyeki TM, van Herp M, Vetter P, Wohl DA, Wolf T, Wolz A, Wurie AH, Yoti Z. New filovirus disease classification and nomenclature. Nat Rev Microbiol. 2019 05; 17(5):261-263. PMID: 30926957.
- Published on 2/6/2019
Bhadelia N, Sauer L, Cieslak TJ, Davey RT, McLellan S, Uyeki TM, Kortepeter MG. Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines. Health Secur. 2019 Jan/Feb; 17(1):46-53. PMID: 30724616.
- Published on 1/4/2019
Bhadelia N. Understanding Lassa fever. Science. 2019 01 04; 363(6422):30. PMID: 30606832.
View 23 more publications: View full profile at BUMC